Centessa Pharmaceuticals (CNTA) Debt Ratio (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Debt Ratio for 4 consecutive years, with 0.16 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 15.21% to 0.16 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.16 through Dec 2025, down 15.21% year-over-year, with the annual reading at 0.16 for FY2025, 15.21% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.16 at Centessa Pharmaceuticals, down from 0.24 in the prior quarter.
  • The five-year high for Debt Ratio was 0.24 in Q3 2025, with the low at 0.12 in Q3 2024.
  • Average Debt Ratio over 4 years is 0.18, with a median of 0.19 recorded in 2023.
  • The sharpest move saw Debt Ratio crashed 36.69% in 2024, then skyrocketed 97.3% in 2025.
  • Over 4 years, Debt Ratio stood at 0.16 in 2022, then skyrocketed by 33.76% to 0.21 in 2023, then dropped by 10.12% to 0.19 in 2024, then decreased by 15.21% to 0.16 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.16, 0.24, and 0.22 for Q4 2025, Q3 2025, and Q2 2025 respectively.